bromley wrote:I wondered why HarryZ had gone quiet. It looks as if he is now working for the Sunday Mirror.
Hey, I tried to get a job with the Sunday Mirror but the UK government wouldn't issue me a working visa
Seriously, the efficacy of the CRABs has been questioned for quite some time. One only needs to read Dr. Behan's Pathogenesis of MS from a few years ago to get a larger picture of how poor the cost/benefit situation is for these drugs. But as usual, good marketing and sales trumps science when it comes to the world of drugs, especially those involving MS.
As we all now know, Tysabri's makers are making a strong effort to take a large chunk of the CRAB's market share away. I doubt it will mean much benefit for MS patients but certainly interesting to follow the action on the "battlefields" as the big pharmas line up against one another!